Form 13-F position report

CORBUS PHARMACEUTICALS HLDG

Reported by MILLENNIUM MANAGEMENT LLC

CRBP CUSIP 21833P103 Manager CIK 0001273087

Reported 0 shares, down 11,585 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2022
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 12 Through Q4 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 414000
2022-03-31 263000
2022-06-30 88000
2022-09-30 2000
2022-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

5 quarters
Quarterly reported position history for CORBUS PHARMACEUTICALS HLDG held by MILLENNIUM MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2022 Reduced 0 -11,585 (-100.0%) 0 $0 2023-02-14
Q3 2022 Reduced 11,585 -337,332 (-96.7%) < 0.01% $2,000 2022-11-14
Q2 2022 Reduced 348,917 -145,133 (-29.4%) < 0.01% $88,000 2022-08-15
Q1 2022 Reduced 494,050 -177,663 (-26.4%) < 0.01% $263,000 2022-05-16
Q4 2021 Reduced 671,713 -4,395 (-0.7%) < 0.01% $414,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

73 managers reported CORBUS PHARMACEUTICALS HLDG for Q4 2022.

Managers reporting CORBUS PHARMACEUTICALS HLDG in Q4 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 4,049,102 +2,347 < 0.01% $447,426 31 qtrs
BlackRock Inc Reduced 2,355,555 -4,286 < 0.01% $260,289 24 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 986,072 -2,347 < 0.01% $108,000 30 qtrs
TWO SIGMA INVESTMENTS LP Added 570,168 +448,002 < 0.01% $63,004 3 qtrs
Ikarian Capital LLC Unchanged 397,168 0 0.01% $43,888 9 qtrs
STATE STREET CORPORATION Unchanged 395,513 0 < 0.01% $43,704 26 qtrs
WELLS FARGO & COMPANY MN Added 342,084 +1,973 < 0.01% $37,800 26 qtrs
FMR LLC Reduced 333,404 -51,200 < 0.01% $36,841 7 qtrs
ACADIAN ASSET MANAGEMENT LLC Added 287,430 +194,258 < 0.01% $31,000 5 qtrs
NORTHERN TRUST CORPORATION Unchanged 207,329 0 < 0.01% $22,910 31 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2022
Filed
February 14, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.